Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time

International Journal of Radiation Oncology, Biology, Physics

Volumn 27, Issue 1, 1993, Pages 125-127

  Hanks, Gerald E ^a   D'amico, Anthony ^a   Epstein, Barry E ^a   Schultheiss, Timothy E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TREATMENT PLANNING; TUMOR GROWTH;

HUMAN; LEAST-SQUARES ANALYSIS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0027202228     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(93)90429-Y     Document Type: Article

References (9)

1. Deferred treatment in clinically localised prostatic carcinoma
2. The prostate
3. High 10-year survival rate in patients with early, untreated prostate cancer
4. Prostate specific antigen as an indicator of response to radiotherapy in prostate cancer
5. The value of serum prostate specific antigen determinations before and after radical prostatectomy
6. Cancer control following anatomical radical prostatectomy: an interim report
7. Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy
8. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
9. Prostate-specific antigen as a serum marker of adenocarcinoma of the prostate